Options trading expert Wendy Kirkland’s free guide reveals the options trading principles that are as easy to implement as they are to learn and how using them could earn you thousands in extra income each month!

Download the guide here and see the difference!

AKBA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.84%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $378,207.89

Akebia Therapeutics Insider Trading History Chart

Akebia Therapeutics Share Price & Price History

^$1.28

▲ +0.08 (6.67%)

As of 06/7/2023 01:00 AM ET

Days: 30 | 90 | 365

Passive Income Powerhouse Unveiled: The Ultimate Play!

From The Oxford Club | Ad

The #1 income play for 2023 is NOT a stock, bond or private company... Rather, it's a little-known alternative investment that could hand you big monthly income from oil and gas.

Find Out What It Is Right Here.

>>>

Akebia Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/25/2023	Michel Dahan	COO	Sell	95,478	$1.22	$116,483.16	574,037
5/25/2023	Nicole R Hadas	SVP	Sell	63,186	$1.22	$77,086.92	524,344
5/16/2023	Steven Keith Burke	SVP	Sell	63,567	$1.07	$68,016.69	530,487
3/1/2023	David A. Spellman	CFO	Sell	7,210	$0.88	$6,344.80	510,050
3/1/2023	John P. Butler	CEO	Sell	91,868	$0.88	$80,843.84	1,568,872
3/1/2023	Michel Dahan	COO	Sell	20,412	$0.88	$17,962.56	269,515
3/1/2023	Nicole R Hadas	SVP	Sell	13,034	$0.88	$11,469.92	287,530
6/3/2022	Steven C Gilman	Director	Sell	4,567	$0.36	$1,644.12	43,430
3/1/2022	David A. Spellman	CFO	Sell	803	$2.17	$1,742.51
2/28/2022	John P. Butler	CEO	Sell	25,053	$2.15	$53,863.95
2/28/2022	Michel Dahan	COO	Sell	6,555	$2.15	$14,093.25
2/28/2022	Steven Keith Burke	SVP	Sell	7,400	$2.15	$15,910.00
2/28/2022	Violetta Cotreau	CAO	Sell	3,946	$2.15	$8,483.90
6/7/2021	Steven C. Gilman	Director	Sell	4,567	$3.32	$15,162.44	47,997
4/1/2021	John P. Butler	CEO	Sell	4,109	$3.40	$13,970.60
4/1/2021	Michel Dahan	COO	Sell	1,211	$3.40	$4,117.40
4/1/2021	Steven Keith Burke	SVP	Sell	1,081	$3.40	$3,675.40
6/8/2020	Maxine Gowen	Director	Sell	4,567	$11.84	$54,073.28

The Safest Option in Trades!

From Tradewins | Ad

If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

Click here now!

SEC Filings (Institutional Ownership Changes) for Akebia Therapeutics (NASDAQ:AKBA)

28.13% of Akebia Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Akebia Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/18/2023	JPMorgan Chase & Co.	81,547	$45K	0.0%	+1,916.5%	0.044%
5/16/2023	Jane Street Group LLC	46,193	$26K	0.0%	-91.6%	0.025%
5/16/2023	State Street Corp	692,836	$0.39M	0.0%	+21.1%	0.373%
5/15/2023	Two Sigma Securities LLC	138,037	$77K	0.0%	+64.8%	0.074%
5/15/2023	Price T Rowe Associates Inc. MD	105,500	$60K	0.0%	-36.8%	0.057%
5/15/2023	Alerce Investment Management L.P.	16,205,119	$9.08M	12.0%	+7.4%	8.716%
5/12/2023	Renaissance Technologies LLC	2,338,500	$1.31M	0.0%	-19.0%	1.258%
5/12/2023	BlackRock Inc.	2,703,523	$1.52M	0.0%	-7.5%	1.454%
5/12/2023	Bank of America Corp DE	193,459	$0.11M	0.0%	+44.6%	0.104%
5/12/2023	Mirabella Financial Services LLP	140,604	$1.83M	0.3%	N/A	0.076%
5/12/2023	HRT Financial LP	148,681	$83K	0.0%	N/A	0.080%
5/12/2023	UBS Group AG	87,975	$49K	0.0%	+49.7%	0.047%
5/12/2023	Charles Schwab Investment Management Inc.	79,804	$45K	0.0%	-39.7%	0.043%
5/12/2023	HighTower Advisors LLC	70,350	$40K	0.0%	+18.4%	0.038%
5/11/2023	Icon Wealth Partners LLC	50,000	$28K	0.0%	N/A	0.027%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	302,977	$0.17M	0.0%	+152.4%	0.163%
5/2/2023	Victory Capital Management Inc.	257,744	$0.14M	0.0%	+1,200.3%	0.140%
5/1/2023	Virtu Financial LLC	97,854	$55K	0.0%	N/A	0.053%
2/15/2023	Public Employees Retirement System of Ohio	149,945	$87K	0.0%	-18.5%	0.082%
2/15/2023	Millennium Management LLC	1,342,422	$0.78M	0.0%	-61.4%	0.730%
2/15/2023	Alerce Investment Management L.P.	15,090,119	$8.71M	10.0%	+224.3%	8.203%
2/14/2023	Two Sigma Investments LP	374,289	$0.22M	0.0%	-30.3%	0.203%
2/13/2023	Renaissance Technologies LLC	2,886,227	$1.67M	0.0%	-4.3%	1.569%
2/13/2023	Geode Capital Management LLC	1,682,498	$0.97M	0.0%	+3.7%	0.915%
2/10/2023	Bank of America Corp DE	133,764	$77K	0.0%	-52.5%	0.073%
2/10/2023	Orchard Capital Management LLC	66,826	$39K	0.0%	-73.5%	0.036%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	120,053	$69K	0.0%	-76.5%	0.065%
2/8/2023	UBS Group AG	58,755	$34K	0.0%	-55.5%	0.032%
11/15/2022	Public Employees Retirement System of Ohio	183,979	$58K	0.0%	N/A	0.100%
11/15/2022	Jacobs Levy Equity Management Inc.	2,042,816	$0.65M	0.0%	+162.7%	1.110%
11/15/2022	Two Sigma Investments LP	537,361	$0.17M	0.0%	+151.6%	0.292%
11/15/2022	Vanguard Group Inc.	13,182,865	$4.17M	0.0%	-18.9%	7.166%
11/15/2022	Price T Rowe Associates Inc. MD	166,900	$54K	0.0%	+254.4%	0.091%
11/15/2022	Marshall Wace LLP	314,316	$0.10M	0.0%	N/A	0.171%
11/15/2022	Federated Hermes Inc.	1,800,536	$0.57M	0.0%	-9.5%	0.979%
11/15/2022	BlackRock Inc.	4,286,956	$1.36M	0.0%	-1.2%	2.330%
11/14/2022	Renaissance Technologies LLC	3,016,427	$0.95M	0.0%	+103.5%	1.640%
11/14/2022	Ergoteles LLC	165,237	$52K	0.0%	-80.5%	0.090%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	510,102	$0.16M	0.0%	+124.9%	0.277%
11/10/2022	Dimensional Fund Advisors LP	627,549	$0.20M	0.0%	-19.8%	0.341%
10/26/2022	Allspring Global Investments Holdings LLC	242,866	$76K	0.0%	+43.8%	0.132%
10/26/2022	Wipfli Financial Advisors LLC	200,000	$63K	0.0%	N/A	0.109%
9/16/2022	Federated Hermes Inc.	1,989,467	$0.70M	0.0%	-2.0%	1.082%
8/18/2022	Goldman Sachs Group Inc.	341,546	$0.12M	0.0%	-62.1%	0.186%
8/17/2022	Parallax Volatility Advisers L.P.	109,683	$39K	0.0%	-68.2%	0.060%
8/15/2022	AQR Capital Management LLC	862,168	$0.30M	0.0%	+367.4%	0.469%
8/15/2022	State Street Corp	573,876	$0.20M	0.0%	-95.0%	0.312%
8/15/2022	Millennium Management LLC	5,354,175	$1.89M	0.0%	+65.8%	2.912%
8/13/2022	Renaissance Technologies LLC	1,482,300	$0.52M	0.0%	+47.7%	0.806%
8/12/2022	Northern Trust Corp	360,526	$0.13M	0.0%	-78.5%	0.196%
8/12/2022	FMR LLC	621,244	$0.22M	0.0%	+177.3%	0.338%
8/12/2022	BNP Paribas Arbitrage SA	90,540	$32K	0.0%	+123.7%	0.049%
8/12/2022	Franklin Resources Inc.	82,473	$29K	0.0%	-32.6%	0.045%
8/11/2022	UBS Group AG	130,652	$46K	0.0%	-83.0%	0.071%
8/10/2022	Principal Financial Group Inc.	414,392	$0.15M	0.0%	+124.1%	0.226%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	226,770	$80K	0.0%	-51.9%	0.124%
7/29/2022	Russell Investments Group Ltd.	225,640	$78K	0.0%	-11.8%	0.123%
7/25/2022	Allspring Global Investments Holdings LLC	168,942	$59K	0.0%	-51.7%	0.092%
7/19/2022	Icon Wealth Partners LLC	400,132	$0.14M	0.0%	N/A	0.218%
6/7/2022	Bank of America Corp DE	404,253	$0.29M	0.0%	-11.9%	0.220%
5/18/2022	BNP Paribas Arbitrage SA	40,474	$29K	0.0%	-42.9%	0.022%
5/17/2022	Virtu Financial LLC	130,949	$94K	0.0%	N/A	0.071%
5/17/2022	Mirabella Financial Services LLP	56,300	$40K	0.0%	N/A	0.031%
5/16/2022	Goldman Sachs Group Inc.	900,967	$0.65M	0.0%	-58.0%	0.491%
5/16/2022	State Street Corp	11,488,224	$8.25M	0.0%	-2.2%	6.259%
5/16/2022	Orchard Capital Managment LLC	1,762,731	$1.27M	0.4%	+10.6%	0.960%
5/16/2022	Invesco Ltd.	279,958	$0.20M	0.0%	+47.1%	0.153%
5/16/2022	UBS Group AG	769,438	$0.55M	0.0%	+59.4%	0.419%
5/13/2022	Renaissance Technologies LLC	1,003,327	$0.72M	0.0%	+61.0%	0.547%
5/13/2022	Northern Trust Corp	1,676,121	$1.20M	0.0%	-4.0%	0.913%
5/13/2022	Charles Schwab Investment Management Inc.	476,974	$0.34M	0.0%	+7.4%	0.260%
5/13/2022	XTX Topco Ltd	102,392	$74K	0.0%	+282.7%	0.056%
5/13/2022	Prudential Financial Inc.	249,912	$0.18M	0.0%	-60.4%	0.136%
5/13/2022	Vanguard Group Inc.	14,402,988	$10.34M	0.0%	+8.8%	7.848%
5/13/2022	Dimensional Fund Advisors LP	2,666,861	$1.92M	0.0%	+2.8%	1.453%
5/12/2022	BlackRock Inc.	13,961,540	$10.02M	0.0%	-1.2%	7.607%
5/12/2022	MetLife Investment Management LLC	85,186	$61K	0.0%	+176.6%	0.046%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	471,681	$0.34M	0.0%	+17.2%	0.257%
5/11/2022	JPMorgan Chase & Co.	4,258,198	$3.06M	0.0%	-3.9%	2.320%
5/11/2022	GSA Capital Partners LLP	54,370	$39K	0.0%	N/A	0.030%
5/9/2022	Principal Financial Group Inc.	184,939	$0.13M	0.0%	-28.5%	0.101%
5/9/2022	Swiss National Bank	393,085	$0.28M	0.0%	+7.8%	0.214%
5/5/2022	Rice Hall James & Associates LLC	513,292	$0.37M	0.0%	+5.6%	0.280%
5/5/2022	Russell Investments Group Ltd.	255,967	$0.18M	0.0%	-19.0%	0.139%
4/25/2022	Assenagon Asset Management S.A.	104,092	$75K	0.0%	N/A	0.059%
2/19/2022	Woodline Partners LP	2,231,966	$5.04M	0.1%	-3.9%	1.276%
2/15/2022	Kennedy Capital Management Inc.	333,841	$0.75M	0.0%	-9.3%	0.191%
2/15/2022	Marshall Wace LLP	4,475,138	$10.11M	0.0%	-35.8%	2.558%
2/14/2022	PDT Partners LLC	433,400	$0.98M	0.1%	-25.5%	0.248%
2/14/2022	Virtus ETF Advisers LLC	69,015	$0.16M	0.1%	+18.5%	0.039%
2/14/2022	Point72 Hong Kong Ltd	13,106	$30K	0.0%	N/A	0.007%
2/14/2022	Rice Hall James & Associates LLC	486,220	$1.10M	0.0%	-14.1%	0.278%
2/14/2022	Blair William & Co. IL	16,599	$38K	0.0%	-27.5%	0.009%
2/10/2022	JPMorgan Chase & Co.	4,432,203	$10.02M	0.0%	-2.9%	2.533%
2/10/2022	Rafferty Asset Management LLC	738,075	$1.67M	0.0%	+9.5%	0.422%
2/10/2022	Teacher Retirement System of Texas	32,286	$73K	0.0%	+37.2%	0.018%
2/10/2022	Connor Clark & Lunn Investment Management Ltd.	402,416	$0.91M	0.0%	-6.6%	0.230%
2/9/2022	Principal Financial Group Inc.	258,563	$0.58M	0.0%	-52.1%	0.148%
2/9/2022	BNP Paribas Arbitrage SA	70,923	$0.16M	0.0%	-9.1%	0.041%
2/9/2022	Dimensional Fund Advisors LP	2,593,841	$5.86M	0.0%	+23.8%	1.483%

Data available starting January 2016

Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vadadustat. The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA.

Today's Range

Now: $1.28

$1.21

$1.32

50 Day Range

MA: $0.89

$0.51

$1.43

52 Week Range

Now: $1.28

$0.24

$1.63

Volume

3,337,857 shs

Average Volume

2,019,949 shs

Market Capitalization

$237.99 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.73

Who are the company insiders with the largest holdings of Akebia Therapeutics?: Akebia Therapeutics' top insider shareholders include:
John P Butler (CEO)
Michel Dahan (COO)
Steven Keith Burke (SVP)
Nicole R Hadas (SVP)
David A Spellman (CFO)
Steven C Gilman (Director)
Steven C Gilman (Director)
Violetta Cotreau (CAO)
Learn More about top insider investors at Akebia Therapeutics.
Who are the major institutional investors of Akebia Therapeutics?: Akebia Therapeutics' top institutional investors include:
Alerce Investment Management L.P. — 8.72%
BlackRock Inc. — 1.45%
Renaissance Technologies LLC — 1.26%
State Street Corp — 0.37%
Connor Clark & Lunn Investment Management Ltd. — 0.16%
Victory Capital Management Inc. — 0.14%
Learn More about top institutional investors of Akebia Therapeutics stock.
Which institutional investors are selling Akebia Therapeutics stock?: Within the last quarter, AKBA stock was sold by these institutional investors:
Renaissance Technologies LLC
Jane Street Group LLC
BlackRock Inc.
Price T Rowe Associates Inc. MD
Charles Schwab Investment Management Inc.
Belvedere Trading LLC
Within the last year, company insiders that have sold Akebia Therapeutics company stock include:
John P Butler (CEO)
Michel Dahan (COO)
Steven Keith Burke (SVP)
Nicole R Hadas (SVP)
David A Spellman (CFO)
Learn More investors selling Akebia Therapeutics stock.
Which institutional investors are buying Akebia Therapeutics stock?: Within the previous quarter, AKBA stock was acquired by institutional investors including:
Alerce Investment Management L.P.
Victory Capital Management Inc.
Connor Clark & Lunn Investment Management Ltd.
HRT Financial LP
Mirabella Financial Services LLP
State Street Corp
Virtu Financial LLC
JPMorgan Chase & Co.